Initially developed for diabetes, GLP-1 therapies have demonstrated up to 20% weight reduction in clinical trials
Tissue-Repair & Regenerative Research Research involving GHK-Cu commonly investigates: Tissue-remodeling pathways Recovery-focused regenerative signaling Fibroblast-related mechanisms Keratinocyte-related pathways Connective-tissue and extracellular-matrix signaling Scar-remodeling and tissue-maintenance research These pathways have contributed to broader research interest in GHK-Cu within regenerative and recovery-focused research models

Key Benefits Enhance GLP-1 receptor activation and sustain its response with a combination of clinically studied prebiotics, probiotics, postbiotics, and fast-acting GLP-1 activators that work synergistically Control appetite by reducing cravings and stimulating satiety signals with hops extract, probiotic, and postbiotic* Promote digestive health and regularity with a prebiotic that promotes the growth of Akkermansia muciniphila for GLP-1 signaling Free from gluten, dairy, peanut, tree nut, fish, shellfish, soy, sesame, egg, active yeast, artificial flavors, colors, sweeteners, and unnecessary excipients
I developed acute IBS, migraines and Fibromyalgia all undiagnosed til a decade or more later
Improved blood sugar control Semaglutide stimulates insulin release when blood sugar is elevated and reduces glucagon production, which improves overall glucose regulation